期刊文献+

他汀类药物对中国老年脓毒症患者住院期间病死率的影响 被引量:3

Effect of statins on in-hospital mortality in elderly Chinese patients with sepsis: a retrospective cohort study
原文传递
导出
摘要 目的探讨他汀类药物对中国老年脓毒症患者住院病死率的影响。方法对212例2009年3月至2012年3月在浙江大学医学院附属第一医院老年科住院的老年脓毒症患者进行研究。以出院为观察终点,将患者分为死亡组和存活组。采用多因素Logistic回归模型分析,以确定应用他汀类药物是否为住院期间病死率的的独立影响因素。结果存活组使用他汀类药物的患者比例高于死亡组[13.9%(5/36)vs.34.7%(61/176),χ^2=6.014,P=0.014],调整后的比值比(OR)有统计学意义(OR:0.17;95%CI:0.04-0.85;P=0.03)。结论他汀类药物的使用可能可以降低中国老年脓毒症患者住院期间的病死率。 Objective To investigate the prognostic value of statins on elderly Chinese patients with sepsis. Methods A total of 212 elderly Chinese patients with sepsis hospitalized in First Affiliated Hospital, Zhejiang University School of Medicine, from March 2009 to March2012 were enrolled into the study. Time to discharge from the hospital was selected as the primary endpoint. All the patients were divided into the death group and survival group, and the variables were compared between the two groups. The multivariate logistic regression was applied to assess the independent risk factors for death among the patients during the hospitalization. Results The proportion of the patients treated by statins continuously in the death group was significantly higher than that in the survival group [13.9%(5 / 36) vs. 34.7%(61 / 176), χ^2= 6.014, P = 0.014], and the statins were the independent predictor for death during hospitalization(OR: 0.17; 95%CI: 0.04- 0.85; P = 0.03). Conclusion Statins may reduce the inhospital mortality in elderly Chinese patients with sepsis.
出处 《中华危重症医学杂志(电子版)》 CAS 2016年第1期34-37,共4页 Chinese Journal of Critical Care Medicine:Electronic Edition
基金 老年病科国家临床重点专科建设项目 浙江省医药卫生一般研究计划(2012KYB084)
关键词 脓毒症 老年人 他汀类药物 住院病死率 Sepsis Elderly Statins In-hospital mortality
  • 相关文献

参考文献20

  • 1Balk RA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations [J]. Crit Care Clin, 2000, 16 (2): 179-192.
  • 2Hotchkiss RS, Karl IE. The pathophysiology and treat- ment of sepsis[J]. N Engl J Med, 2003, 348 (2): 138- 150.
  • 3Terblanche M, Almog Y, Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels[J]. Lancet Infect Dis, 2007, 7 (5): 358-368.
  • 4Jasinska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and con- sequent pleiotropic effects[J]. Pharmacol Rep, 2007, 59 (5): 483-499.
  • 5Kouroumichakis I, Papanas N, Proikaki S, et al. Sta- tins in prevention and treatment of severe sepsis and septic shock[J]. Eur J Intern Med, 2011, 22 (2): 125- 133.
  • 6Yang KC, Chien JY, Tseng WK, et al. Statins do not improve short-term survival in an oriental population with sepsis[J]. Am J Emerg Med, 2007, 25 (5): 494- 501.
  • 7American College of Chest Physicians/Society of Criti- cal Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992, 20 (6): 864-874.
  • 8Mortensen EM, Pugh MJ, Copeland LA, et al. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia[J]. Eur Respir J, 2008, 31 (3): 611-617.
  • 9Fogerty MD, Efron D, Morandi A, et al. Effect of p- reinjury statin use on mortality and septic shock in el- derly burn patients [J]. J Trauma, 2010, 69 (1): 99- 103.
  • 10Calisto KL, Carvalho Bde M, Ropelle ER, et al. Ator- vastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling[J]. PLoS One, 2010, 5 (12): e14232.

同被引文献32

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部